Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T14:17:11.306Z.
Consensus retrieved: 2026-10-06T12:56:36.646Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T14:17:11.306Z.
Quote observation: 2026-10-06T14:13:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49c5230cca2432c6fd0637270100fe2f3d02ebc9238e4fdbb1f4ddcca099658b
FORWARD PE RATIO
N/A
iSpecimen Inc.
Market Cap
$2.64M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| iSpecimen Inc. (ISPC) | $2.64M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.53M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.50M | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.35M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.99M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.11M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $1.05, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $0.00 | $0.00 – $0.00 | 0 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
